How Long Does Mounjaro Stay in Your System? (UK)

You've had your last injection. Maybe you've decided to stop, maybe you're moving to a different treatment, maybe a surgeon or a fertility clinic has asked when the medication will be out of your body. The question underneath all of those is the same one: how long does Mounjaro stay in your system?

The number people usually want is 25 to 30 days. On its own that number isn't much use, because what you're really asking is probably something more specific. When will my appetite come back? When is it safe to start something else? Is there anything I can do to speed this up?

The short answer: roughly a month

Tirzepatide has an elimination half-life of approximately five days, according to the Mounjaro Summary of Product Characteristics held on the electronic medicines compendium. A half-life is the time it takes for the amount in your bloodstream to halve. Pharmacology treats a drug as effectively gone after about five half-lives, and five multiplied by five gives you 25 days.

That's where the familiar figure comes from. It's arithmetic, not a measurement. Nobody has taken a group of patients, tested them on day 26 and declared them tirzepatide-free. Half-lives describe a curve that flattens towards zero without ever quite touching it, so any "clearance date" is a reasonable convention rather than a hard line.

Which is why the honest answer is a range. Around 25 days for the bulk of it. Closer to 30, sometimes a little beyond, if you'd been injecting for months.

How long Mounjaro stays in your system, day by day

If you want to see the shape of it, here's what the maths gives you for a single injection.

One wrinkle worth knowing about. Those figures describe one dose sitting on its own. If you've been injecting weekly for more than a month, every dose lands before the previous one has finished leaving, and the total amount in your body settles at a plateau. The SmPC puts that steady state at four weeks of once-weekly dosing, and the arithmetic works out at roughly 1.6 times what a single injection alone would leave behind.

So a person stopping after eight months has a bit more to shift than someone stopping after their third injection. Not dramatically more. Enough to explain why the range runs to 30 days rather than stopping neatly at 25.

Why it stops feeling like it's working long before it's gone

Plenty of patients notice hunger creeping back by day five or six of their injection week and reasonably conclude the medication has run out. It hasn't. Half of it is still there.

Concentration peaks somewhere between 8 and 72 hours after you inject, according to the pharmacokinetic data in the European Medicines Agency product information. From that peak it slides gently downwards all week. Appetite suppression tracks that slide, and the point at which you consciously notice hunger returning is a threshold effect, not an empty tank.

This is also why taking your dose a day or two late rarely causes chaos, and why taking it a day early is usually fine as long as you keep enough space between injections. The drug in your system is a slow-moving reservoir, not a tap that switches off.

Does your metabolism, liver or kidneys change how fast it clears?

Almost every article on this topic says yes. Fast metabolism, slower clearance if your kidneys are struggling, longer if your liver isn't in great shape, more if you carry more weight.

The regulatory data says otherwise, and it's fairly emphatic. The SmPC states plainly that renal impairment does not impact the pharmacokinetics of tirzepatide, tested across mild, moderate and severe impairment as well as end-stage renal disease. It says the same about hepatic impairment. It also states that age, gender, race, ethnicity and body weight have no clinically relevant effect on how tirzepatide behaves in the body.

There's a mechanistic reason for that. Tirzepatide is a 39-amino-acid peptide with a fatty diacid tail attached, and that tail binds it tightly to albumin in your blood, around 99% of it. It isn't processed by the liver enzymes that handle most tablets, and it isn't filtered out intact by your kidneys. Your body dismantles it by proteolytic cleavage, essentially taking the peptide apart the way it handles other proteins, and the resulting fragments leave via urine and faeces. Intact tirzepatide is never found in either.

So the organs that usually create variation in drug clearance aren't doing the work here.

What actually changes over the month after your last dose

Knowing the numbers is one thing. Knowing what the month feels like is more useful.

The first week or so: very little happens. The medication is still at close to therapeutic levels, appetite stays suppressed, and any side effects you were living with usually carry on. If you stopped because of nausea or other side effects, this is the frustrating stretch where nothing has improved yet.

Weeks two and three: the curve steepens in practical terms. Hunger signals sharpen. Food noise, that constant low background hum of thinking about eating, tends to return gradually rather than all at once, and many people describe noticing it in the second or third week. Gastrointestinal side effects usually ease over the same period.

Week four onwards: by now you're mostly working with your own appetite regulation again. If you have type 2 diabetes, blood glucose can drift upwards as the effect fades, which is why the NHS advises talking to your doctor rather than stopping suddenly.

Weight regain is a separate question from clearance and runs on a much longer clock. It isn't inevitable, and it isn't a failure of willpower when it happens. Appetite has simply gone back to what it was.

When the five-day half-life actually matters

Most of the time you never need to think about any of this. There are five situations where it becomes practical.

Planning a pregnancy: the NHS advice on tirzepatide is to stop at least four weeks before you start trying to conceive, and the SmPC gives the same instruction, specifically citing the long half-life as the reason. Four weeks is not an arbitrary buffer. It's the clearance window.

Contraception: related, and often missed. Tirzepatide slows stomach emptying, which can reduce how much of an oral contraceptive gets absorbed. The NHS advises using an additional barrier method for four weeks after starting Mounjaro and for four weeks after every dose increase.

Surgery, sedation and dental procedures: delayed gastric emptying means there may be food in your stomach when an anaesthetist expects it to be empty, which carries an aspiration risk. Tell whoever is doing the procedure that you're on tirzepatide, and tell them well in advance. Given the five-day half-life, a couple of days' notice isn't enough for anyone to plan around.

Switching treatments: if you're moving to a different GLP-1 medication, your prescriber is working with an overlap rather than a clean handover. That's why switching from Mounjaro to Wegovy usually starts at a low dose rather than matching what you were on.

Missed doses: the NHS rule is straightforward. If it's been four days or less since you should have injected, take it as soon as you remember. If it's been longer than four days, skip it and go back to your usual day. Never double up. And if you want to move your injection day, leave at least three days between doses.

Does a higher dose stay in your system longer?

Yes and no, and most articles muddle the distinction.

The half-life doesn't change with dose. Tirzepatide clears at the same proportional rate whether you're on 2.5 mg or 15 mg, so the percentage table above applies identically to everyone. Twenty-five days after your last injection, roughly 3% of whatever you took is still there.

What changes is the absolute amount. Three per cent of 15 mg is six times more drug than 3% of 2.5 mg. If you're on the maximum dose, the tail is longer in the sense that a meaningful quantity persists for a while after a starter-dose patient's would have dropped below anything that matters. It's the same curve, starting higher up.

In practice this is why people stepping down from 12.5 mg or 15 mg often describe a slower, gentler return of appetite than someone stopping at 2.5 mg. Bring it up with your prescriber if you're planning a break rather than a full stop. The same logic applies when you're settling on a maintenance dose.

Does Mounjaro show up on a drug test?

No. Standard workplace and roadside drug screens look for a defined panel of substances, and tirzepatide isn't on any of them. Beyond that, intact tirzepatide isn't excreted in urine or faeces at all. Your body breaks it into peptide fragments first, so there's nothing recognisable to find even if someone went looking.

If you're asked to declare medications for a medical, a pre-operative assessment or an insurance form, do declare it. That's a different situation entirely, and one where being upfront matters.

How does that compare with Wegovy?

Half-lives vary across this class of medicine, which is why switching advice differs depending on what you're coming off.

Those semaglutide figures come straight from its Summary of Product Characteristics, which states that with a half-life of approximately one week, semaglutide is present in the circulation for about five weeks after the last dose.

The gap shows up in the advice around pregnancy. Tirzepatide should be stopped a month before trying to conceive. For semaglutide the SmPC says two months. Same principle, different arithmetic.

The bottom line

You can report any side effect you experience on the MHRA Yellow Card website.

This article is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare professional before starting any treatment.